SEC Form 4 · accession 0001171843-15-004826
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur S Kirsch
Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 20, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $1.91 | Aug 18, 2015 | A | 22,500 | A | Aug 18, 2015 | Aug 18, 2022 | Common Stock, par value $0.01 per share | 22,500 | 22,500 | D |